Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomo Nozawa

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Modern Rheumatology|November 17, 2016
Primary varicella infection in children with systemic juvenile idiopathic arthritis under tocilizumab therapyTomo Nozawa, Kenichi Nishimura, Asami Ohara, et al.
Pediatrics International : Official Journal of the Japan Pediatric Society|June 20, 2025
Intolerance of oral methotrexate in juvenile idiopathic arthritisAi Yuda, Tomo Nozawa, Seira Hattori, et al.
Pediatrics International : Official Journal of the Japan Pediatric Society|December 17, 2015
Usefulness of two interferon-γ release assays for rheumatic diseaseTomo Nozawa, Masaaki Mori, Kenichi Nishimura, et al.
Modern Rheumatology|March 5, 2024
Evaluation of medication withdrawal in patients with non-systemic juvenile idiopathic arthritis in Japan using a web-based surveyTakasuke Ebato, Takayuki Kishi, Keiji Akamine, et al.
ACR Open Rheumatology|March 11, 2022
Impaired Interleukin-18 Signaling in Natural Killer Cells From Patients With Systemic Juvenile Idiopathic ArthritisTakashi Ohya, Kenichi Nishimura, Ayako Murase, et al.
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|January 8, 2013
[Febrile responses in patients with pediatric rheumatic diseases]Shumpei Yokota, Masako Kikuchi, Tomo Nozawa, et al.
The Journal of Rheumatology|February 17, 2012
Efficacy and limitation of infliximab treatment for children with Kawasaki disease intractable to intravenous immunoglobulin therapy: report of an open-label case seriesMasaaki Mori, Tomoyuki Imagawa, Ryoki Hara, et al.
Modern Rheumatology|May 21, 2014
Pathogenesis of systemic inflammatory diseases in childhood: "Lessons from clinical trials of anti-cytokine monoclonal antibodies for Kawasaki disease, systemic onset juvenile idiopathic arthritis, and cryopyrin-associated periodic fever syndrome"Shumpei Yokota, Masako Kikuchi, Tomo Nozawa, et al.
Scientific Reports|June 19, 2023
Characteristics of persistent arthritis with refractory Kawasaki disease: a single-center retrospective studySeira Hattori, Tomo Nozawa, Kenichi Nishimura, et al.
Pediatric Rheumatology Online Journal|February 18, 2021
Tibia stress injury and the imaging appearance of stress fracture in juvenile dermatomyositis: six patients' experiencesTomo Nozawa, Audrey Bell-Peter, Andrea S Doria, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Modern Rheumatology|November 17, 2016
Primary varicella infection in children with systemic juvenile idiopathic arthritis under tocilizumab therapyTomo Nozawa, Kenichi Nishimura, Asami Ohara, et al.
Pediatrics International : Official Journal of the Japan Pediatric Society|June 20, 2025
Intolerance of oral methotrexate in juvenile idiopathic arthritisAi Yuda, Tomo Nozawa, Seira Hattori, et al.
Pediatrics International : Official Journal of the Japan Pediatric Society|December 17, 2015
Usefulness of two interferon-γ release assays for rheumatic diseaseTomo Nozawa, Masaaki Mori, Kenichi Nishimura, et al.
Modern Rheumatology|March 5, 2024
Evaluation of medication withdrawal in patients with non-systemic juvenile idiopathic arthritis in Japan using a web-based surveyTakasuke Ebato, Takayuki Kishi, Keiji Akamine, et al.
ACR Open Rheumatology|March 11, 2022
Impaired Interleukin-18 Signaling in Natural Killer Cells From Patients With Systemic Juvenile Idiopathic ArthritisTakashi Ohya, Kenichi Nishimura, Ayako Murase, et al.
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|January 8, 2013
[Febrile responses in patients with pediatric rheumatic diseases]Shumpei Yokota, Masako Kikuchi, Tomo Nozawa, et al.
The Journal of Rheumatology|February 17, 2012
Efficacy and limitation of infliximab treatment for children with Kawasaki disease intractable to intravenous immunoglobulin therapy: report of an open-label case seriesMasaaki Mori, Tomoyuki Imagawa, Ryoki Hara, et al.
Modern Rheumatology|May 21, 2014
Pathogenesis of systemic inflammatory diseases in childhood: "Lessons from clinical trials of anti-cytokine monoclonal antibodies for Kawasaki disease, systemic onset juvenile idiopathic arthritis, and cryopyrin-associated periodic fever syndrome"Shumpei Yokota, Masako Kikuchi, Tomo Nozawa, et al.
Scientific Reports|June 19, 2023
Characteristics of persistent arthritis with refractory Kawasaki disease: a single-center retrospective studySeira Hattori, Tomo Nozawa, Kenichi Nishimura, et al.
Pediatric Rheumatology Online Journal|February 18, 2021
Tibia stress injury and the imaging appearance of stress fracture in juvenile dermatomyositis: six patients' experiencesTomo Nozawa, Audrey Bell-Peter, Andrea S Doria, et al.
Pageof 4